Characteristics | Effective treatment cohort | Ineffective treatment cohort | p value |
---|---|---|---|
Age, year | 63.27 ± 10.73 | 69.38 ± 10.05 | 0.010* |
Gender | Â | Â | 0.096 |
Male | 49 (47.1%) | 17 (65.4%) | Â |
Female | 55 (52.9%) | 9 (34.6%) | Â |
Tumor pathology | Â | Â | 0.387 |
Primary | 20 (19.2%) | 7 (26.9%) | Â |
Metastasis | 84 (80.8%) | 19 (73.1%) | Â |
Tumor indicators | Â | Â | 0.927 |
Absent | 37 (35.6%) | 17 (65.4%) | Â |
Present | 67 (64.4%) | 9 (34.6%) | Â |
Systematic treatment | Â | Â | 0.093 |
Absent | 66 (63.4%) | 21 (80.8%) | Â |
Present | 38 (36.5%) | 5 (19.2%) | Â |
Tumor Size | 12.50 (9.03, 17.15) | 20.05 (12.53, 31.83) | <0.001* |
Minimum GGO margin depth | 5.93 ± 1.98 | 4.78 ± 1.82 | 0.008* |
Maximum GGO margin depth | 11.95 (9.75, 15.88) | 11.30 (8.38, 15.73) | 0.331 |
Density | Â | Â | 0.558 |
Solid | 89 (85.6%) | 24 (92.3%) | Â |
Non-Solid | 15 (14.4%) | 2 (7.7%) | Â |
Location | Â | Â | 0.725 |
Upper middle lobe | 56 (53.8%) | 13 (50.0%) | Â |
Lower lobe | 48 (46.2%) | 13 (50.0%) | Â |
Adjacent large blood vessels | Â | Â | 0.088 |
Absent | 67 (64.4%) | 12 (46.2%) | Â |
Present | 37 (35.6%) | 14 (53.8%) | Â |
Adjacent large bronchus | Â | Â | 0.001* |
Absent | 96 (92.3%) | 17 (65.4%) | Â |
Present | 8 (7.7%) | 9 (34.6%) | Â |
Margin | Â | Â | 0.065 |
Smooth | 72 (69.2%) | 13 (50.0%) | Â |
Rough | 32 (30.8%) | 13 (50.0%) | Â |
Pleural pull | Â | Â | 0.170 |
Absent | 26 (25.0%) | 16 (61.5%) | Â |
Present | 78 (75.0%) | 10 (38.5%) | Â |